8-K: Owens & Minor Releases Preliminary Q2 2024 Results, Reaffirms Full-Year Guidance

Owens & Minor announced preliminary second quarter 2024 financial results and reaffirmed its full-year 2024 guidance, despite a one-time tax charge.

Summary

• Owens & Minor has released preliminary financial results for the second quarter of 2024, showing revenue between $2.651 billion and $2.671 billion.
• The company reported a GAAP operating income between $16 million and $20 million, and an adjusted non-GAAP operating income between $72 million and $76 million.
• The GAAP net loss is between $35 million and $32 million, while the adjusted non-GAAP net income is between $25 million and $28 million.
• Adjusted EBITDA for the quarter is between $123 million and $127 million.
• The company experienced a GAAP net loss per common share between $0.46 and $0.42, and an adjusted non-GAAP net income per share between $0.32 and $0.36.
• Operating cash flow for the quarter is between $111 million and $116 million.
• Total debt and net debt reduction for the quarter is between $68 million and $71 million.
• A one-time income tax charge of $17 million, or $0.22 per share, was recorded due to a recent decision related to past transfer pricing methodology.
• The company expects to make a related cash payment of $30-$35 million in the second half of the year.
• Owens & Minor has reaffirmed its full-year 2024 guidance, with revenue expected to be between $10.5 billion and $10.9 billion.
• Adjusted EBITDA for 2024 is projected to be between $550 million and $590 million, and adjusted EPS is expected to be between $1.40 and $1.70.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the reaffirmation of full-year guidance and debt reduction, despite a GAAP net loss and a one-time tax charge. The company's outlook is stable, but there are some risks to consider.

Positives

• The company reaffirmed its full-year 2024 guidance, indicating confidence in its performance.
• The company achieved a reduction in total debt and net debt of $68-$71 million in the second quarter.
• The company's adjusted EBITDA for Q2 2024 is within the expected range.
• The company believes the tax matter will be concluded without further impact to its financial results.

Negatives

• The company reported a GAAP net loss for the second quarter of 2024.
• A one-time income tax charge of $17 million negatively impacted the GAAP results.
• The company expects to make a related cash payment of $30-$35 million in the second half of the year related to the tax matter.

Risks

• The company's 2024 outlook is based on assumptions that are subject to risk factors discussed in the company's SEC filings.
• The company's outlook includes assumptions about general economic conditions, inflation, and pricing and demand pressures in the Products & Healthcare Services segment.
• The company's results could be impacted by unpredictable restructuring and acquisition charges.
• The company's results could be impacted by litigation and related charges.

Future Outlook

The company reaffirms its full-year 2024 guidance, with revenue expected to be between $10.5 billion and $10.9 billion, adjusted EBITDA between $550 million and $590 million, and adjusted EPS between $1.40 and $1.70. This outlook excludes the impact of the Rotech acquisition.

Management Comments

• Owens & Minor executives will host a conference call for investors and analysts on Friday, August 2, 2024, at 8:30 a.m. ET.
• The company believes the tax matter will be concluded without further impact to its financial results.

Industry Context

Owens & Minor operates in the healthcare solutions industry, providing essential products and services. The company's performance is influenced by factors such as general economic conditions, inflation, and pricing and demand pressures in the healthcare sector. The company's focus on cost-saving initiatives and operational efficiency is consistent with industry trends.

Comparison to Industry Standards

• It is difficult to make a direct comparison without knowing the specific performance of Owens & Minor's direct competitors in the same period.
• However, the company's revenue guidance of $10.5 billion to $10.9 billion for the full year is a key metric to compare against other healthcare distributors such as Cardinal Health and McKesson.
• The adjusted EBITDA guidance of $550 million to $590 million should be compared to the EBITDA margins of its peers to assess profitability.
• The company's debt reduction of $68-$71 million is a positive sign, but the overall debt level of $2.083 billion to $2.085 billion should be compared to industry averages and benchmarks.
• The one-time tax charge of $17 million is a specific event that needs to be considered in the context of the company's overall financial health and compared to similar events in the industry.

Legal Proceedings

• The company recorded a one-time income tax charge of $17 million related to a recent decision associated with Notices of Proposed Adjustments received in 2020 and 2021 regarding past transfer pricing methodology.

Stakeholder Impact

• Shareholders will be interested in the company's financial performance and future outlook.
• Employees may be impacted by the company's cost-saving initiatives.
• Customers will be interested in the company's ability to provide essential products and services.
• Creditors will be interested in the company's debt reduction and overall financial health.

Next Steps

• The company will release full results on Friday, August 2 before the NYSE open.
• Owens & Minor executives will host a conference call for investors and analysts on Friday, August 2, 2024, at 8:30 a.m. ET.

Key Dates

Keywords

financial results, preliminary results, second quarter, Q2 2024, full-year guidance, revenue, EBITDA, EPS, debt reduction, tax charge, healthcare solutions